S&P ASX All Technology

US Dollar vs AUD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

LTRN Lantern Pharma Inc

3.25

0.073 (2.30%)

21 Dec 2024 - Closed

Delayed by 15 minutes

Form EFFECT - Notice of Effectiveness

Lantern Pharma (NASDAQ:LTRN)
Historical Stock Chart
From Nov 2024 to Dec 2024

Click Here for more Lantern Pharma Charts.

Lantern Pharma (NASDAQ:LTRN)
Historical Stock Chart
From Dec 2023 to Dec 2024

Click Here for more Lantern Pharma Charts.

Lantern Pharma Inc News

Lantern Pharma Announces First Patient Enrolled in Taiwan for Phase 2 HARMONIC™ Clinical Trial of LP-300 in Never-Smoker NSCLC Patients
Tuesday 10 December 2024 (2 weeks ago) • Business Wire

Lantern Pharma's Investigational Drug-Candidate, LP-184, Receives Second Fast Track Designation from FDA for Treatment of Triple Negative Breast Cancer (TNBC)
Wednesday 4 December 2024 (3 weeks ago) • Business Wire

Lantern Pharma & Starlight Therapeutics Present LP-184 (STAR-001) Phase 1b Trial Design and Preclinical Data in Glioblastoma at Society for Neuro-Oncology (SNO) 2024 Highlighting Novel Synthetic Lethality
Wednesday 27 November 2024 (4 weeks ago) • Business Wire

Lantern Pharma Announces First Patient Dosed in Japan for The Expansion Cohort in The Phase 2 HARMONIC™ Clinical Trial of LP-300 in Never-Smoker NSCLC Patients
Wednesday 20 November 2024 (1 month ago) • Business Wire

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Friday 8 November 2024 (1 month ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 8 November 2024 (1 month ago) • Edgar (US Regulatory)

Lantern Pharma Reports Third Quarter 2024 Financial Results and Business Updates
Friday 8 November 2024 (1 month ago) • Business Wire

Starlight Therapeutics Announces Inaugural Members of Scientific Advisory Board
Wednesday 6 November 2024 (2 months ago) • Business Wire

Lantern Pharma to Report Third Quarter 2024 Operating & Financial Results on November 7th, 2024 at 4:30 p.m. ET
Thursday 31 October 2024 (2 months ago) • Business Wire

Lantern Pharma to Present at the ThinkEquity Conference in NYC on October 30, 2024
Wednesday 23 October 2024 (2 months ago) • Business Wire

Lantern Pharma to Host & Participate in Two Public Webinars During October
Monday 21 October 2024 (2 months ago) • Business Wire

Lantern Pharma’s Investigational Drug-Candidate, LP-184, Receives Fast-Track Designation in Glioblastoma from the FDA
Wednesday 16 October 2024 (2 months ago) • Business Wire

More Lantern Pharma Inc News Articles

Westpac Banking

National Australia Bank

S&P ASX 300 Metals and M...

AUD vs US Dollar

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions